2. Search Result
Search Result
Results for "

Neopterin

" in MedChemExpress (MCE) Product Catalog:

5

Inhibitors & Agonists

2

Natural
Products

1

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-W040055
    Neopterin

    D-(+)-Neopterin; D-erythro-Neopterin

    		 Endogenous Metabolite Inflammation/Immunology
    Neopterin (D-(+)-Neopterin), a catabolic product of guanosine triphosphate (GTM), serves as a marker of cellular immune system activation.
    Neopterin
  • HY-W040055R
    Neopterin (Standard)

    		Endogenous Metabolite Inflammation/Immunology
    Neopterin (Standard) is the analytical standard of Neopterin. This product is intended for research and analytical applications. Neopterin (D-(+)-Neopterin), a catabolic product of guanosine triphosphate (GTM), serves as a marker of cellular immune system activation.
    Neopterin (Standard)
  • HY-W040055S
    Neopterin-13C5

    D-(+)-Neopterin-13C5; D-erythro-Neopterin-13C5

    		 Isotope-Labeled Compounds Endogenous Metabolite Others
    Neopterin- 13C5 (D-(+)-Neopterin- 13C5; D-erythro-Neopterin- 13C5) is the deuterium labeled Neopterin (HY-W040055) . Neopterin (D-(+)-Neopterin), a catabolic product of guanosine triphosphate (GTM), serves as a marker of cellular immune system activation .
    Neopterin-13C5
  • HY-W040055A
    L-(-)-Neopterin

    L-erythro-Neopterin

    		 mAChR Neurological Disease Metabolic Disease
    L-(-)-Neopterin (L-erythro-Neopterin) is a cholinergic receptor that acts as a competitive antagonist, countering the inhibitory effects of pteridine diuretics on the growth of Crithidia fasciculata. L-(-)-Neopterin can be used in research related to the nervous system and purine metabolism .
    L-(-)-Neopterin
  • HY-W750595
    6-(L-1,2,3-Trihydroxybutyl)-pterin

    		Drug Derivative Cancer
    6-(L-1,2,3-Trihydroxybutyl)-pterin is a derivative of L-biopterin (HY-102015) and is the oxidized form of tetrahydro-L-biopterin (BH4) as well as D-biopterin. Co-ingestion of 6-(L-1,2,3-Trihydroxybutyl)-pterin (0.5%) with the carcinogen 4-dimethylaminoazobenzene reduces the incidence of 4-dimethylaminoazobenzene-induced liver tumors in rats. 6-(L-1,2,3-Trihydroxybutyl)-pterin has been used as an internal standard for the LC-MS quantification of biopterin and neopterin in rat plasma.
    6-(L-1,2,3-Trihydroxybutyl)-pterin